The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Walsh Matthew M since year 2005.
The trader's CIK number is 1269428.
At the time of this reporting, Walsh Matthew M is the EVP, Chief Financial Officer of Allergan Plc .
(stock ticker symbol AGN).
See this page for all insider trading activities at Allergan Plc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-08||CTLT||Catalent, Inc.||Option Ex||74,651||12.79||954,413|
|2016-05-27||CTLT||Catalent, Inc.||Option Ex||89,124||16.14||1,438,728|
|2015-07-27||CTLT||Catalent, Inc.||Option Ex||84,717||11.90||1,008,386|
|2015-04-06||CTLT||Catalent, Inc.||Option Ex||102,043||10.71||1,092,880|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Walsh Matthew M (EVP, Chief Financial Officer of Allergan Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.